pregnantech tv.PNG

Initial publicity at the 1st World Congress on Women’s Health Innovation and Inventions, Tel Aviv, Israel

PregnanTech receives approval from Ethics committees of two hospitals to conduct first-in-woman safety clinical studies

USPTO issues Notice of Allowance for PregnanTech’s patent application

First in Human (FIM) safety clinical study among women before hysterectomy. Findings attest to the great potential of the device.

© PregnanTech 2020